Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Primary Immunodeficiency Database in Japan.

Kanako Mitsui-Sekinaka1, Yujin Sekinaka1, Akifumi Endo2

  • 1Department of Pediatrics, National Defense Medical College, Saitama, Japan.

Frontiers in Immunology
|January 27, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.

International journal of hematology·2026
Same author

Assessment of TREC-Based NBS SCID Reporting Practices for Harmonization of Results and Interpretation: A Global Survey.

The journal of allergy and clinical immunology. In practice·2026
Same author

Trends of Treatments for Pediatric Patients with Immune Thrombocytopenia in Japan.

Annals of clinical epidemiology·2026
Same author

Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant.

Journal of clinical immunology·2026
Same author

Analysis of intracellular organelles in neurons differentiated from iPSCs of Chédiak-Higashi syndrome patients.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

A practical tip for estimating skeletal maturation in children aged < 3 years using humeral ossification on chest radiographs: A retrospective study.

European journal of pediatrics·2026

The Primary Immunodeficiency Database in Japan (PIDJ) collects patient data for primary immunodeficiency diseases (PIDs). Upgraded to PIDJ ver.2, it now supports research into PIDs and autoinflammatory diseases (AIDs).

Area of Science:

  • Immunology
  • Genetics
  • Epidemiology

Background:

  • The Primary Immunodeficiency Database in Japan (PIDJ) was established in 2007 to register primary immunodeficiency diseases (PIDs).
  • It is a collaborative project involving major research institutions and government bodies.
  • The database collects comprehensive patient data, including clinical, laboratory, and genetic information.

Purpose of the Study:

  • To establish a comprehensive registry for PIDs in Japan.
  • To facilitate early diagnosis, treatment, and research into PID pathogenesis.
  • To provide a platform for patient consultation and connect physicians with specialists.

Main Methods:

  • Data collection from enrolled patients, including demographics, clinical findings, infections, genetic analysis, and treatments.
Keywords:
Japanese Society for Immunodeficiency and Autoinflammatory DiseasesPrimary Immunodeficiency Database in Japanconsultationgenetic analysispathogenesisprimary immunodeficiency

Related Experiment Videos

  • Web-based case consultation services.
  • Expansion of the database and biobank construction by the Japanese Society for Immunodeficiency and Autoinflammatory Diseases (JSIAD).

    • Main Results:

    • As of 2016, 4,481 patients were enrolled in the PIDJ.
    • Genetic analysis was performed on 64% of the enrolled patients.
    • The database has facilitated investigations into disease pathogenesis and treatment.

    Conclusions:

    • The PIDJ has been instrumental in advancing the understanding and management of PIDs in Japan.
    • The establishment of JSIAD and the upgrade to PIDJ ver.2 have expanded its scope to include autoinflammatory diseases (AIDs).
    • PIDJ ver.2 serves as a crucial platform for ongoing epidemiological studies, genetic analysis, and pathogenesis evaluation of PIDs and AIDs.